KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInvested CapitalNet Margin

National Health Investors (NHI) EBITDA Margin (2016 - 2019)

Historic EBITDA Margin for National Health Investors (NHI) over the last 11 years, with Q3 2019 value amounting to 76.46%.

  • National Health Investors' EBITDA Margin fell 24800.0% to 76.46% in Q3 2019 from the same period last year, while for Sep 2019 it was 75.76%, marking a year-over-year decrease of 23700.0%. This contributed to the annual value of 92.55% for FY2019, which is 9500.0% down from last year.
  • Per National Health Investors' latest filing, its EBITDA Margin stood at 76.46% for Q3 2019, which was down 24800.0% from 75.55% recorded in Q2 2019.
  • National Health Investors' EBITDA Margin's 5-year high stood at 96.43% during Q3 2015, with a 5-year trough of 54.4% in Q2 2016.
  • Its 5-year average for EBITDA Margin is 80.83%, with a median of 77.67% in 2018.
  • Per our database at Business Quant, National Health Investors' EBITDA Margin skyrocketed by 398000bps in 2015 and then crashed by -414900bps in 2016.
  • Quarter analysis of 5 years shows National Health Investors' EBITDA Margin stood at 94.98% in 2015, then grew by 1bps to 95.76% in 2016, then fell by -17bps to 79.34% in 2017, then decreased by -1bps to 78.93% in 2018, then dropped by -3bps to 76.46% in 2019.
  • Its last three reported values are 76.46% in Q3 2019, 75.55% for Q2 2019, and 71.18% during Q1 2019.